GeneDx Holdings Corp. (WGS) Profit Margin
GeneDx Holdings Corp. (WGS) gross and net profit margin history with trends. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2020-12-31 | -134.58% |
| 2021-12-31 | -115.64% |
| 2022-12-31 | -233.91% |
| 2023-12-31 | -86.77% |
| 2024-12-31 | -17.12% |
| 2025-12-31 | -4.92% |
How WGS compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| MNKD | MannKind Corporation | 1.68% |
| HROW | Harrow Inc Com | -1.89% |
| AKBA | Akebia Therapeutics Inc. | -2.26% |
| AXGN | Axogen Inc. | -6.97% |
| HRTX | Heron Therapeutics Inc. | -13.04% |
These are five companies in the same sector as WGS with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get GeneDx Holdings Corp. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("WGS", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | WGS | $81.74 | +4.96% | 0.65M |
| 3 | ||||
| 4 | ||||
| 5 |